NCT04238793 - Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions

Neuropathic Pain From Lumbosacral Radiculopathy

Interventions

DRUG

KLS-2031

KLS-2031 administered by transforaminal epidural injection

OTHER

Placebo

Normal Saline (0.9%) administered by transforaminal epidural injection

Trial Locations (1)

Kolon Investigative Site : CenExel JBR, Salt Lake City